← Eichor
Study identifier: NCT06954714 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions

Condition: Coronary Artery Disease  ·  Sponsor: Chonnam National University Hospital

PhaseNA
Planned participants256
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to compare late-lumen loss (LLL) between DCB and DES to treat de novo coronary artery stenosis by intravascular ultrasound (IVUS).

This description comes directly from the study's public registry record.

Talk to the study team

Seung Hun Lee, MD, PhD  ·  +82-62-220-6246  ·  lsh8602@naver.com

Joon Ho Ahn, MD, PhD  ·  +82-62-220-5778  ·  yhbky@naver.com

Always discuss trial participation with your own doctor first.

Locations (8)

Kosin University Gospel HospitalBusan, Busan, South KoreaNot Yet Recruiting
Keimyung University Dongsan HospitalDaegu, Daegu, South KoreaNot Yet Recruiting
Chonnam National UniversityGwangju, Gwangju, South KoreaRecruiting
Jeonbuk National University HospitalJeonju, Jeonju, South KoreaNot Yet Recruiting
Samsung Medical CenterSeoul, Seoul, South KoreaNot Yet Recruiting
Ewha Womans University Mokdong HospitalSeoul, Seoul, South KoreaNot Yet Recruiting
Korea University Guro HospitalSeoul, Seoul, South KoreaNot Yet Recruiting
Ulsan University HospitalUlsan, Ulsan, South KoreaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06954714